Novartis announced that HER-MES, the first Phase IV, randomized, double-blind, double-dummy, head-to-head study of Aimovig (erenumab) against topiramate , an anticonvulsant, in patients with episodic and chronic migraine met its primary and secondary endpoints.
Objective: To develop recommendations for disease-modifying therapy (DMT) for multiple sclerosis (MS).
An FDA study of more than 134,000 patients found that Pradaxa (dabigatran etexilate mesylate), from Boehringer, was associated with significantly...
Wellvone Suspension is indicated for: Acute treatment of mild to moderate Pneumocystis pneumonia (PCP, caused by Pneumocystis jiroveci , formerly classified as P. carinii ) (alveolar - arterial oxygen tension difference [(A-a) DO 2 ] ≤ 45 mmHg (6 kPa) and oxygen tension in arterial blood (PaO 2 ) ≥ 60 mmHg (8 kPa) breathing room air) in patients who are intolerant of co-trimoxazole therapy (see section 4.4).
Regeneron Pharmaceuticals, Inc. and Sanofi announced that the FDA has approved Kevzara (sarilumab) for the treatment of polymyalgia rheumatica (PMR), an inflammatory rheumatic disease, in adult patients who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper
Background: Benralizumab is an anti-eosinophilic, anti-interleukin-5 receptor α monoclonal antibody that has been shown to significantly reduce asthma exacerbations and improve lung function for patients with severe, uncontrolled asthma.
Review the latest digest 'Initiation of a fixed‐dose four‐factor prothrombin complex concentrate protocol'.